With the PSKY WBD acquisition, let's say you have WBD $25 c and they settle on 25 or above per share, how expensive do those calls go since its guaranteed to hit ? Or what if the acquisition price is cheaper than the strike price ?
Very interesting. I like what I see so far, but damn, it'll be the year 2030 or so before phase 3 trial would even start. This is a chance to get in early, but between now and then it could be all over the place, might go to $10, might go to 0.28 per share, on delayed trials and cash burn.
The the C-peptide pee test at 6 months showing the cells are surviving is strong so far.
Hard call, I wouldn't take options, they are overpriced due to IV at the moment, she's a long term buy and hold.
If the price tanks and the test results continue to hold, I may throw my hat in the ring. I don't think it's undervalued at all honestly. A sample size of 2 and proof of concept is where it's at, This market Cap with good phase 1 results, then I would consider it undervalued.
But it's just my opinion, others will differ.
Also at 10am today, chart reading here it looks like buyers dumped their shares into the buying activity with the sudden spike and fall, probably bag holders from the last time it rised a few months ago who bought at the top.